Adaptive Pharmacotherapy for Tobacco Dependence

What is the Purpose of this Study?

We are doing this study to look at a new combination of already approved treatments to help people quit smoking.
What is the Condition Being Studied?
Smoking

Who Can Participate in this Study?

Adults who:

- Smoke greater than or equal to 5 cigarettes per day

- Do not abuse alcohol or drugs

- Are not pregnant

- Have no history of seizures

Age Group
Adults
Participating Institutions

What is Involved?

If you choose to join this study, you will:

- Choose 12 weeks of Chantix (pill) or Nicotine Patch

- Have 5 study visits over 4 months

- Complete tests/assessments and self-report diaries at each visit

Study Details

Full Title
Randomized-Controlled Smoking Cessation Trial on Adaptive Pharmacotherapy
Principal Investigator

Contacts
Protocol Number
IRB:
PRO00072077

NCT:
NCT02501265
ClinicalTrials.gov
View on ClinicalTrials.gov